查看購物車
  • Simplified Chinese
  • English
  • Japanese
亞太地區基因分型市場預測至 2031 年 - 區域分析 - 按產品類型、技術、應用、最終用戶
市場調查報告書
商品編碼
1666234

亞太地區基因分型市場預測至 2031 年 - 區域分析 - 按產品類型、技術、應用、最終用戶

Asia Pacific Genotyping Market Forecast to 2031 - Regional Analysis - by Product Type, Technology, Application, End user
出版日期: | 出版商: The Insight Partners | 英文 160 Pages | 訂單完成後即時交付

價格

2023 年亞太地區基因分型市值為 64.8996 億美元，預計到 2031 年將達到 350.4862 億美元；預計 2023 年至 2031 年的複合年成長率將達到 23.5%。

應用範圍不斷擴大，推動亞太地區基因分型市場發展

基因分型在診斷研究、藥物基因體學和農業生物技術中具有潛在的應用。此外，該技術適用於各種植物育種、法醫和環境測試程序。製藥公司正在從多基因風險評分、與患者健康資訊相關的大量基因資料庫以及臨床試驗參與者的測序資料等進步中獲利。產業藥物基因組學工作小組 (I-PWG) 是一個製藥公司協會，積極參與藥物基因組學研究。 I-PWG 由 26 家成員公司組成，每年進行大量臨床試驗，並根據協議收集研究對象的 DNA 樣本。 I-PWG 專注於臨床藥物基因組學，旨在未來幾年為製藥公司創造機會。除了在腫瘤學研究中最頻繁的用途外，它還用於非腫瘤學治療領域（如罕見疾病、免疫學和心臟病學）進行的 PGx 研究。一項更全面的研究涉及臨床試驗樣本的NGS，可以對試驗參與者進行詳細的基因組評估，揭示常見和罕見的基因變異。 PGx 包括研究基因組層級的藥物/外來化合物效應、藥物反應和疾病易感性以及基因型/表現型關係中的多態性差異。

定序基因分型（GBS）是一種利用NGS方法對農作物基因組和人類基因組中的SNP進行定位和基因分型的新方法。 GBS 透過在定序過程中加入分子標記來開發和部署，用於對多個樣本進行定序，以進一步增強 NGS 在玉米和小麥等大型作物基因組定序中的應用。 GBS檢測的高通量SNP廣泛應用於許多植物物種的遺傳多樣性分析、全基因組關聯研究（GWAS）、QTL定位和基因組預測（GP）。 NGS技術以高通量和低成本改變了現代生物學。隨著 NGS 技術的顯著進步，全基因組定序提供了超通量序列，徹底改變了植物性因分型和育種。邊合成邊定序（SBS）和連接複用大大提高了序列的效率。

因此，各個研究領域更廣泛地採用基因分型最終將導致對這些技術的需求增加，從而為市場創造巨大的機會。

亞太地區基因分型市場概覽

亞太地區的基因分型市場細分為印度、中國、日本、澳洲、韓國和亞太其他地區。技術進步的激增、 DNA 測序價格的下降、亞洲和西方國家之間的合作（用於基因組研究的發展）的激增以及遺傳疾病和其他目標疾病的患病率上升是推動亞太地區基因分型市場發展的因素之一。

亞太地區基因分型市場收入及預測（2031 年）（百萬美元）

亞太地區基因分型市場細分

亞太地區基因分型市場分為產品類型、技術、應用、最終用戶和國家。

根據產品類型，亞太地區基因分型市場分為儀器、試劑和試劑盒、生物資訊學和基因分型服務。試劑和試劑盒部分在 2023 年佔據了最大的市場佔有率。

依技術分類，亞太地區基因分型市場分為微陣列、毛細管電泳、定序、聚合酶鍊式反應 (PCR)、基質輔助雷射解吸/MALDI-TOF 和其他技術。聚合酶鏈反應 (PCR) 領域在 2023 年佔據了最大的市場佔有率。

根據應用，亞太地區基因分型市場分為藥物基因組學、診斷和個人化醫療、動物遺傳學、農業生物技術和其他應用。 2023 年，診斷和個人化醫療領域佔據最大的市場佔有率。

就最終用戶而言，亞太地區基因分型市場分為製藥和生物製藥公司、診斷和研究實驗室、學術機構和其他最終用戶。 2023 年，製藥和生物製藥公司部門佔據了最大的市場佔有率。

依國家分類，亞太基因分型市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2023年，中國佔據亞太地區基因分型市場的主導佔有率。

Hoffmann-La Roche Ltd、QIAGEN NV、Merck KGaA、XCELRIS GENOMICS、Thermo Fisher Scientific Inc、BioTek Instruments Inc、Illumina Inc、Danaher Corp、Bio-Rad Laboratories Inc、GE HealthCare Technologies Inc、Standard BioTools Inc、Laboratory Corp of America、Sooratory Corp of。是亞太地區基因分型市場的一些領導公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 發育基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：亞太地區基因分型市場格局

  • 概述
  • 全球市佔率分析
    • NGS 文庫製備主要參與者的全球市佔率（%）
    • 基因分型領導企業的全球市場佔有率（%）
    • 基因表現領域領導企業的全球市場佔有率（%）

第 5 章：亞太地區基因分型市場 - 主要市場動態

  • 市場促進因素：
    • 用於診斷遺傳疾病和罕見疾病
    • 生物技術和製藥行業的技術進步和研發投資不斷增加
  • 市場限制
    • 設備成本高，專業技術人員短缺
  • 市場機會
    • 擴大應用範圍
  • 未來趨勢
    • 個人化醫療日益普及
  • 促進因素和限制因素的影響：

第 6 章：基因分型市場 - 亞太地區分析

  • 2021 至 2031 年基因分型市場收入

第 7 章：亞太地區基因分型市場分析 - 依產品類型

  • 儀器
  • 試劑和試劑盒
  • 生物資訊學
  • 基因分型服務

第 8 章：亞太地區基因分型市場分析 - 按技術

  • 微陣列
  • 毛細管電泳
  • 定序
  • 聚合酶鍊式反應（PCR）
  • 基質輔助雷射解吸/MALDI-TOF
  • 其他技術

第 9 章：亞太地區基因分型市場分析 - 按應用

  • 藥物基因組學
  • 診斷及個人化醫療
  • 動物遺傳學
  • 農業生物技術
  • 其他應用

第 10 章：亞太地區基因分型市場分析 - 依最終用戶

  • 製藥和生物製藥公司
  • 診斷與研究實驗室
  • 學術機構
  • 其他最終用戶

第 11 章：亞太地區基因分型市場 - 國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 12 章：產業格局

  • 概述
  • 基因分型市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Merck KGaA
  • EUROFINS GENOMICS
  • Thermo Fisher Scientific Inc
  • BioTek Instruments, Inc.
  • XCELRIS GENOMICS
  • TRIMGEN CORPORATION
  • Illumina Inc
  • Danaher Corp
  • Bio-Rad Laboratories Inc
  • GE HealthCare Technologies Inc
  • Standard BioTools Inc
  • Laboratory Corp of America Holdings
  • Beckman Coulter Inc
  • BGI
  • Takara Bio Inc
  • DiaSorin SpA

第 14 章：附錄

Product Code: BMIRE00025968

The Asia Pacific genotyping market was valued at US$ 6,489.96 million in 2023 and is expected to reach US$ 35,048.62 million by 2031; it is estimated to record a CAGR of 23.5% from 2023 to 2031.

Expanding Range of Applications Boosts Asia Pacific Genotyping Market

Genotyping holds potential applications in diagnostic research, pharmacogenomics, and agricultural biotechnology. Moreover, this technique is suitable for a variety of plant breeding, forensic, and environmental testing procedures. Pharmaceutical companies are profiting from the availability of polygenic risk scores, substantial genetic databases linked to patient health information, and the sequencing data of clinical trial participants, among other advancements. The Industry Pharmacogenomics Working Group (I-PWG), an association of pharmaceutical companies, is actively involved in pharmacogenomic research. The I-PWG comprises 26member companies that undertake numerous clinical trials annually, collecting DNA samples of study subjects as part of the protocol. With its focus on clinical pharmacogenomics, the I-PWG aims to generate opportunities for pharmaceutical companies in the coming years. In addition to its most frequent use in oncology research, it is also used for PGx studies conducted in non-oncology therapeutic areas such as rare diseases, immunology, and cardiology. A more comprehensive study, involving the NGS of clinical trial samples, allows for an elaborate genomic evaluation of trial participants, revealing both common and rare genetic variations. PGx includes the study of polymorphic differences in the determination of genomic-level drug/xenobiotic effects, drug response and disease susceptibility, and genotype/phenotype relationships.

Genotyping-by-sequencing (GBS) is a new method to locate and genotype SNPs in crop genomes and human genome by using NGS methods. GBS is developed and deployed in sequencing multiple samples by incorporating molecular markers in the process to further enhance NGS applications in giant crop genome sequencing, such as maize and wheat. High-throughput SNPs detected by GBS are widely used in genetic diversity analysis, genome-wide association studies (GWAS), QTL mapping, and genome prediction (GP) in many plant species. NGS technology has transformed modern biology with high throughput and low cost. With remarkable advancements unlocked by NGS technologies, whole-genome sequencing provides ultra-throughput sequences that revolutionize plant genotyping and breeding. Sequencing by synthesis (SBS) and multiplexing greatly enhances the efficiency of the sequence.

Therefore, greater adoption of genotyping in various research areas would eventually lead to a rise in the demand for these techniques, creating significant opportunities in the market.

Asia Pacific Genotyping Market Overview

The genotyping market in Asia Pacific is sub-segmented into India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. An upsurge in technological advancements, decreasing prices of DNA sequencing, the surge in collaborations (for the development of genomic research) among Asian and Western countries, and the rising prevalence of genetic and other target diseases are among the factors propelling the APAC genotyping market.

Asia Pacific Genotyping Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Genotyping Market Segmentation

The Asia Pacific genotyping market is categorized into product type, technology, application, end user, and country.

Based on product type, the Asia Pacific genotyping market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment held the largest market share in 2023.

By technology, the Asia Pacific genotyping market is segmented into microarrays, capillary electrophoresis, sequencing, polymerase chain reaction (PCR), matrix-assisted laser desorption / MALDI-TOF, and other technologies. The polymerase chain reaction (PCR) segment held the largest market share in 2023.

Based on application, the Asia Pacific genotyping market is bifurcated into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and other applications. The diagnostics and personalized medicine segment held the largest market share in 2023.

In terms of end user, the Asia Pacific genotyping market is bifurcated into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and other end users. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.

By country, the Asia Pacific genotyping market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific genotyping market share in 2023.

Hoffmann-La Roche Ltd, QIAGEN NV, Merck KGaA, XCELRIS GENOMICS, Thermo Fisher Scientific Inc, BioTek Instruments Inc, Illumina Inc, Danaher Corp, Bio-Rad Laboratories Inc, GE HealthCare Technologies Inc, Standard BioTools Inc, Laboratory Corp of America Holdings, Beckman Coulter Inc, BGI, Takara Bio Inc, and DiaSorin SpA. are some of the leading companies operating in the Asia Pacific genotyping market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Genotyping Market Landscape

  • 4.1 Overview
  • 4.2 Global Market Share Analysis
    • 4.2.1 Global Market Share (%) of Leading Players for NGS Library Preparation
    • 4.2.2 Global Market Share (%) of Leading Player for Genotyping
    • 4.2.3 Global Market Share (%) of Leading Player for Gene Expression

5. Asia Pacific Genotyping Market - Key Market Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 Use in Diagnosis of Genetic and Rare Diseases
    • 5.1.2 Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Equipment and Shortage of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Expanding Range of Applications
  • 5.4 Future Trends
    • 5.4.1 Increasing Popularity of Personalized Medicine
  • 5.5 Impact of Drivers and Restraints:

6. Genotyping Market - Asia Pacific Analysis

  • 6.1 Genotyping Market Revenue (US$ Million), 2021-2031

7. Asia Pacific Genotyping Market Analysis - by Product Type

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Reagents and Kits
    • 7.2.1 Overview
    • 7.2.2 Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Bioinformatics
    • 7.3.1 Overview
    • 7.3.2 Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Genotyping Services
    • 7.4.1 Overview
    • 7.4.2 Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Genotyping Market Analysis - by Technology

  • 8.1 Microarray
    • 8.1.1 Overview
    • 8.1.2 Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Capillary Electrophoresis
    • 8.2.1 Overview
    • 8.2.2 Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Sequencing
    • 8.3.1 Overview
    • 8.3.2 Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Polymerase Chain Reaction (PCR)
    • 8.4.1 Overview
    • 8.4.2 Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Matrix-Assisted Laser Desorption / MALDI-TOF
    • 8.5.1 Overview
    • 8.5.2 Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Other Technologies
    • 8.6.1 Overview
    • 8.6.2 Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Genotyping Market Analysis - by Application

  • 9.1 Pharmacogenomics
    • 9.1.1 Overview
    • 9.1.2 Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Diagnostics and Personalized Medicine
    • 9.2.1 Overview
    • 9.2.2 Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Animal Genetics
    • 9.3.1 Overview
    • 9.3.2 Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Agricultural Biotechnology
    • 9.4.1 Overview
    • 9.4.2 Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Other Applications
    • 9.5.1 Overview
    • 9.5.2 Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Genotyping Market Analysis - by End-user

  • 10.1 Pharmaceutical and Biopharmaceutical Companies
    • 10.1.1 Overview
    • 10.1.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Diagnostic and Research Laboratories
    • 10.2.1 Overview
    • 10.2.2 Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Academic Institutes
    • 10.3.1 Overview
    • 10.3.2 Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Other End Users
    • 10.4.1 Overview
    • 10.4.2 Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Genotyping Market - Country Analysis

  • 11.1 Asia Pacific
    • 11.1.1 Asia Pacific: Genotyping Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 China: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.1.1 China: Genotyping Market Breakdown, by Product Type
        • 11.1.1.1.2 China: Genotyping Market Breakdown, by Technology
        • 11.1.1.1.3 China: Genotyping Market Breakdown, by Application
        • 11.1.1.1.4 China: Genotyping Market Breakdown, by End-user
      • 11.1.1.2 Japan: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.2.1 Japan: Genotyping Market Breakdown, by Product Type
        • 11.1.1.2.2 Japan: Genotyping Market Breakdown, by Technology
        • 11.1.1.2.3 Japan: Genotyping Market Breakdown, by Application
        • 11.1.1.2.4 Japan: Genotyping Market Breakdown, by End-user
      • 11.1.1.3 India: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.3.1 India: Genotyping Market Breakdown, by Product Type
        • 11.1.1.3.2 India: Genotyping Market Breakdown, by Technology
        • 11.1.1.3.3 India: Genotyping Market Breakdown, by Application
        • 11.1.1.3.4 India: Genotyping Market Breakdown, by End-user
      • 11.1.1.4 Australia: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.4.1 Australia: Genotyping Market Breakdown, by Product Type
        • 11.1.1.4.2 Australia: Genotyping Market Breakdown, by Technology
        • 11.1.1.4.3 Australia: Genotyping Market Breakdown, by Application
        • 11.1.1.4.4 Australia: Genotyping Market Breakdown, by End-user
      • 11.1.1.5 South Korea: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.5.1 South Korea: Genotyping Market Breakdown, by Product Type
        • 11.1.1.5.2 South Korea: Genotyping Market Breakdown, by Technology
        • 11.1.1.5.3 South Korea: Genotyping Market Breakdown, by Application
        • 11.1.1.5.4 South Korea: Genotyping Market Breakdown, by End-user
      • 11.1.1.6 Rest of APAC: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.6.1 Rest of APAC: Genotyping Market Breakdown, by Product Type
        • 11.1.1.6.2 Rest of APAC: Genotyping Market Breakdown, by Technology
        • 11.1.1.6.3 Rest of APAC: Genotyping Market Breakdown, by Application
        • 11.1.1.6.4 Rest of APAC: Genotyping Market Breakdown, by End-user

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Genotyping Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 QIAGEN NV
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Merck KGaA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 EUROFINS GENOMICS
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Thermo Fisher Scientific Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 BioTek Instruments, Inc.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 XCELRIS GENOMICS
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 TRIMGEN CORPORATION
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Illumina Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Danaher Corp
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Rad Laboratories Inc
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 GE HealthCare Technologies Inc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Standard BioTools Inc
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Laboratory Corp of America Holdings
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Beckman Coulter Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 BGI
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Takara Bio Inc
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 DiaSorin SpA
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Genotyping Market Segmentation
  • Table 2. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 3. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Genotyping Market - Revenue and Forecast to 2031 (US$ Million) - by End-user
  • Table 6. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 7. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 8. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 9. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 10. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 11. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 12. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 13. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 14. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 15. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 16. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 17. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 18. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 19. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 20. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 22. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 23. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 24. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 26. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Product Type
  • Table 27. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Technology
  • Table 28. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 29. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million) - by End-user
  • Table 30. Recent Organic Growth Strategies in Genotyping Market
  • Table 31. Recent Inorganic Growth Strategies in the Genotyping Market
  • Table 32. Glossary of Terms, Genotyping Market

List Of Figures

  • Figure 1. Asia Pacific Genotyping Market Segmentation, by Country
  • Figure 2. Genotyping Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Genotyping Market Revenue (US$ Million), 2021-2031
  • Figure 5. Genotyping Market Share (%) - by Product Type (2023 and 2031)
  • Figure 6. Instruments: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Reagents and Kits: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Bioinformatics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Genotyping Services: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Genotyping Market Share (%) - by Technology (2023 and 2031)
  • Figure 11. Microarray: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Capillary Electrophoresis: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Sequencing: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Polymerase Chain Reaction (PCR): Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Other Technologies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Genotyping Market Share (%) - by Application (2023 and 2031)
  • Figure 18. Pharmacogenomics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Diagnostics and Personalized Medicine: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Animal Genetics: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Agricultural Biotechnology: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Other Applications: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Genotyping Market Share (%) - by End-user (2023 and 2031)
  • Figure 24. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Diagnostic and Research Laboratories: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Academic Institutes: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Other End Users: Genotyping Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Asia Pacific Genotyping Market, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 29. Asia Pacific: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 30. China: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Japan: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. India: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Australia: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. South Korea: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Rest of APAC: Genotyping Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Growth Strategies in Genotyping Market